Meyka Pro banner
Johnson & Johnson

Johnson & Johnson (JNJ) Stock Overview

Explore Johnson & Johnson’s financial performance, market position, analyst ratings, and future outlook.

JNJNYSE
HealthcareDrug Manufacturers - General
$250.61
$1.79(0.72%)
U.S. Market opens in 15h 31m

Johnson & Johnson (JNJ)

Meyka AI Score

Z

Key Financials

Market Cap603.6B
P/E Ratio28.78
EPS (TTM)$10.73
ROE0.26%
Fundamental Analysis

AI Price Forecasts

1 Month$282.11
3 Months$286.90
1 Year Target$199.08

JNJ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Johnson & Johnson (JNJ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.72, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $199.08.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 28.78 and a market capitalization of 603.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.77%
5-Day Change
0.74%
1-Month Change
8.41%
3-Month Change
10.87%
6-Month Change
15.01%
Year-to-Date (YTD) Change
21.16%
1-Year Change
52.56%
3-Year Change
47.33%
5-Year Change
47.94%
All-Time (Max) Change
20452.46%

Contact Information

732 524 0400
One Johnson & Johnson Plaza, New Brunswick, NJ, 08933

Company Facts

1,417,000 Employees
IPO DateJan 2, 1962
CountryUS
Actively Trading

Frequently Asked Questions